I am a gynecologist with over 30 years experience in clinical gynecology and an Associate Professor in Ob/Gyn at FIU's Herbert Wertheim College of Medicine. However I am particularly interested in cancer prevention. As such, my career over the past 18 years has been largely devoted to breast and ovarian cancer risk stratification and managment. An integral part of this is identification of carriers of hereditary cancer. In line with this, in 2020, I was appointed by the then president of ACOG Dr Eva Chalas' Presidential Task Force on Knowledge Gaps in Breast and Ovarian Cancer Risk Assessment, Management and Genetic Testing, and created an educational webinar and slide deck available to ACOG fellows. Prior to Covid, I was a speaker for the nonprofit Bright Pink, educating countless physicians and other integral health care providers on breast and ovarian cancer risk assessment, managment and genetic tresting, and I educated health care providers for various commercial genomic labs. As part of ACOGâs District XII Advisory Board and Patient Safety/Quality chair, I created an educational curriculum on breast/ovarian cancer risk assessment, management and genetic testing that I have given to providers in Florida and nationally over many years. Finally I founded the nonprofit Yodeah, whose mission is to educate the Ashkenazi Jewish community on their increased risk of carrying a BRCA mutation, and facilitate medical-grade, cost-effective testing; and I co-founded the Prevent Hereditary Cancer Coalition with the late Lauren Corduck from One in Forty. I am also on the advisory board of DenseBreast-info.com, a non-profit educating physicians and the community about mammographically dense breasts, increased risk of breast cancer and decreased sensitivity of screening mammograms in those patients. As part of these organizations, I have been educating physicians as well as laypersons on risk assessment, as well as managment, and helping patients advocate for the appropriate breast cancer screening based on their indivudual risk.
I am a gynecologist with over 30 years experience in clinical gynecology and an Associate Professor in Ob/Gyn at FIU's Herbert Wertheim College of Medicine. However I am particularly interested in cancer prevention. As such, my career over the past 18 years has been largely devoted to breast and ovarian cancer risk stratification and managment. An integral part of this is identification of carriers of hereditary cancer. In line with this, in 2020, I was appointed by the then president of ACOG Dr Eva Chalas' Presidential Task Force on Knowledge Gaps in Breast and Ovarian Cancer Risk Assessment, Management and Genetic Testing, and created an educational webinar and slide deck available to ACOG fellows. Prior to Covid, I was a speaker for the nonprofit Bright Pink, educating countless physicians and other integral health care providers on breast and ovarian cancer risk assessment, managment and genetic tresting, and I educated health care providers for various commercial genomic labs. As part of ACOG’s District XII Advisory Board and Patient Safety/Quality chair, I created an educational curriculum on breast/ovarian cancer risk assessment, management and genetic testing that I have given to providers in Florida and nationally over many years. Finally I founded the nonprofit Yodeah, whose mission is to educate the Ashkenazi Jewish community on their increased risk of carrying a BRCA mutation, and facilitate medical-grade, cost-effective testing; and I co-founded the Prevent Hereditary Cancer Coalition with the late Lauren Corduck from One in Forty. I am also on the advisory board of DenseBreast-info.com, a non-profit educating physicians and the community about mammographically dense breasts, increased risk of breast cancer and decreased sensitivity of screening mammograms in those patients. As part of these organizations, I have been educating physicians as well as laypersons on risk assessment, as well as managment, and helping patients advocate for the appropriate breast cancer screening based on their indivudual risk.
